Impact of Cell-Free Fetal DNA Screening on Patients’ Choice of Invasive Procedures after a Positive California Prenatal Screen Result

Until recently, maternal serum analyte levels paired with sonographic fetal nuchal translucency measurement was the most accurate prenatal screen available for Trisomies 18 and 21, (91% and 94% detection and false positive rates of 0.31% and 4.5% respectively). Women with positive California Prenata...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Forum T., Steinhaus French, Kathryn, Osann, Kathryn E., Bocian, Maureen, Jones, Marilyn C., Korty, Lauren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449655/
https://www.ncbi.nlm.nih.gov/pubmed/26237481
http://dx.doi.org/10.3390/jcm3030849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449655/
https://www.ncbi.nlm.nih.gov/pubmed/26237481
http://dx.doi.org/10.3390/jcm3030849

Ejemplares similares